UPDATE 1-FDA rejects Pacira's application for expanded use of pain drug
March 02, 2015 at 07:21 AM EST
March 2 (Reuters) - The U.S. Food and Drug Administration rejected Pacira Pharmaceuticals Inc's application for expanding the use of its post-surgery pain drug, Exparel.
